The purpose of this medicated barrier is defined by two primary therapeutic applications: the fundamental need for protection and the desire for symptomatic modification during sexual activity. The product is applied across domains where additional symptomatic support is needed, involving both proactive health measures and symptomatic management. The core applications of this product confirm its dual benefit.

The product is commonly used to help with addressing symptoms related to heightened physiological activity, particularly symptoms related to physical discomfort and symptoms that interfere with daily functioning. This may assist in managing symptoms related to the timing of climax and is relevant when supportive symptom management is appropriate. In situations requiring defense, it is used for prevention of sexually transmitted infections and unintended pregnancy. This approach helps address groups of symptoms that may become intense or disruptive, and provides support that helps ease the overall symptom burden. “The primary applications address symptomatic relief in performance contexts, delivered alongside supportive prophylactic protection.” Quick Fact: Relevant for Easing Symptoms.

Regulatory References

1. U.S. Food and Drug Administration (FDA) Clearance Documents

Official Population Eligibility Status

The official regulatory profile for Durex Performa Condoms is determined by constraints related to both the natural rubber latex device component and the active ingredient, Benzocaine, a topical local anesthetic. Eligibility is strictly limited to certain populations, with absolute contraindications and conditional restrictions clearly defined in official governmental labeling.

Category	Regulatory Eligibility Rule
Contraindicated Populations	Users with a known allergy to Natural Rubber Latex (due to the device component) or Benzocaine (due to the drug) must not use the product.
Age-Based Exclusion	The Benzocaine component is contraindicated for use in children younger than 2 years of age due to the serious risk of methemoglobinemia.
Conditional Restrictions	Use is prohibited on inflamed or broken skin in the area of application, as documented in official labeling.
Comorbidity Caution	Individuals with a documented history of Methemoglobinemia or underlying conditions such as asthma, heart disease, or anemia are at greater risk of complications.
Pregnancy/Lactation	If the partner is pregnant or breastfeeding, official regulatory labeling advises users to seek advice from a healthcare professional before use.
Older Adults	The older adult population is identified as being at greater risk for methemoglobinemia-related complications, requiring special consideration.

Eligibility is strictly non-existent for groups with component-specific allergies, and use is formally restricted for those with pre-existing conditions that increase systemic risk, as defined in regulatory documents.

The interaction profile for the active ingredient, Benzocaine, is dominated by two primary, officially documented pharmacodynamic interaction categories. These involve an additive risk with other oxidizing agents and a functional antagonism with specific drug classes.

Additive Pharmacodynamic Risk

Classification	Interacting Agents (Classes and Specifics)
Additive Methemoglobinemia Risk	Co-administration with other methemoglobin-inducing agents can result in a documented additive risk of methemoglobinemia. Specific interacting medicines explicitly listed in regulatory-aligned data include Dapsone and nitrate derivatives (e.g., isosorbide, nitroglycerin).
Food / Substance Interaction	The consumption of nitrates and nitrites found in food or water is officially noted to induce methemoglobin formation that is additive to the effect caused by Benzocaine exposure.

Pharmacodynamic Inhibitory Interaction

Certain regulatory documents note a specific inhibitory interaction where Benzocaine can decrease the action of Sulphonamide-class medicines (e.g., sulfamethoxazole, sulfasalazine). This is documented as a functional restriction, with some labeling advising against concomitant use.

Population-Specific Interaction Notes

Individuals with specific inherited deficiencies are recognized by regulatory bodies as having a heightened risk profile for methemoglobinemia. These include deficiencies such as Glucose-6-phosphodiesterase deficiency (G6PD deficiency), Hemoglobin-M disease, NADH-methemoglobin reductase deficiency, and Pyruvate-kinase deficiency.

The official documentation does not contain explicit requirements for separation of administration time (timing-based rules) or detailed pharmacokinetic interactions altering Benzocaine exposure.

Benzocaine's Action on Peripheral Nerve Conduction

This section details the primary pharmacological action of the product, focusing on the active ingredient, benzocaine. Benzocaine acts as a local sodium channel blocker on sensory nerve membranes, which temporarily impedes the flow of electrical signals along these fibers. This mechanism results in a localized reduction in tactile responsiveness through the attenuation of afferent signal magnitude.

Mechanical Mechanism: Barrier Function and Separation

In addition to the pharmacological effect, the product provides a fundamental physical mechanism of action through the inert latex sheath. This barrier mechanically separates the contact surfaces, preventing direct tissue-to-tissue friction and fluid exchange. This is concurrent with the modulation of neural signaling and contributes to the overall effect profile through mechanical containment and structural separation.

How to Use Durex Performa Condoms

Official Administration Guidelines

Usage of Durex Performa Condoms is governed by its classification as a combination product—a medical device (latex sheath) integrated with a drug substance (Benzocaine). The product's administration is strictly external and topical, utilizing the condom as a delivery system for the Benzocaine, which is incorporated into the lubricant on the inner tip of the sheath.

---

Administration Scope

Feature	Guideline
Route of administration	Topical/Local (Applied externally to the penis). The drug component is delivered to the localized area via the lubricant.
Dosing schedule	One (1) condom per single act of sexual intercourse. The product is restricted to single-use only.
Frequency pattern	As-needed (on-demand) use, applied only immediately prior to sexual contact.

---

Procedural Instructions

The official usage protocol requires specific handling and post-use steps. The product is pre-lubricated and ready for application without external preparation. Before use, the condom wrapper must be opened carefully by tearing at the serrated edge to prevent damage to the latex.

After use, the unit is not reusable and must be removed and discarded immediately following ejaculation or the conclusion of intercourse. A mandatory procedural requirement is that the penis must be washed after removal of the condom to address residual lubricant and the topical active ingredient. The product is intended for adult use only and is regulated for Over-the-Counter (OTC) outpatient use.

Research Evidence / Overview of Studies for Durex Performa Condoms

---

Evidence for Use in Prolonging Intercourse Duration

Research has been conducted to examine how the Durex Performa condom, which contains a small amount of the numbing agent Benzocaine, is associated with measurements of the time it takes to ejaculate (Intravaginal Ejaculation Latency Time, or IELT). Studies explored this outcome mainly through short-term randomized controlled trials (RCTs). These trials typically compared the IELT measurements of users with the Performa condom against those using a regular, non-medicated condom. Research has explored whether this approach was associated with differences in the duration of intercourse.

Studies monitored IELT changes which were observed to be typically longer when the Benzocaine-containing condom was used compared to the control condom in these short-term settings. The research describes findings that study participants perceived a difference in the duration of intercourse. Findings describe group patterns observed in the studies but do not determine whether an individual will respond similarly outside of the specific study conditions.

---

Quality of Evidence and Key Research Limitations

The research on Durex Performa contributes to the broader evidence landscape, primarily through manufacturer-sponsored trials and published comparisons. However, sample sizes were modest in some studies, and evidence quality varies across studies based on design and methodology. The reliance on patient-reported outcomes and timing, which can introduce variability, is a key limitation.

Follow-up durations were limited in most available research. Long-term effects are not fully established regarding the consistency of the observed patterns over many months of use. Data for certain groups remain insufficient, meaning results apply primarily to the general adult populations studied, and certainty remains low when extrapolating these findings to all individual users.

Common questions about Durex Performa Condoms (FAQ)

Q: How does the benzocaine actually work at a cellular level?

Official pharmacological information indicates that benzocaine, the active ingredient, works as a local anesthetic. It achieves its effect by binding to voltage-gated sodium channels, which are proteins located within the sensory nerve membranes. This binding action temporarily blocks the necessary flow of sodium ions, preventing the nerves from sending electrical signals, thereby attenuating localized sensation.

Q: Do I need to wash my hands or penis after I take the condom off?

Official usage instructions include a mandatory procedural requirement that the penis must be washed immediately after removal of the condom. This step is required to address residual lubricant and the active ingredient, Benzocaine, from the localized area, as part of the official procedural guidelines. While the instructions focus on the penis, maintaining general hygiene, such as washing hands, is also recommended.

Q: Does the product affect the action of other specific drugs like sulfa medicines?

Official interaction data note that Benzocaine can reduce the effectiveness of sulphonamide-class medicines (often called sulfa drugs), such as sulfamethoxazole or sulfasalazine. This occurs because the Benzocaine is metabolized into a substance that can functionally interfere with the antibacterial action of the sulphonamide drug. Official regulatory documents sometimes advise against the concomitant use of these products due to the documented interaction.

Q: What should I do if my skin turns blue or gray after use?

If symptoms such as pale, gray, or blue-colored skin, lips, or nail beds are noticed, these may be signs of methemoglobinemia, a rare but serious blood condition. Regulatory communications advise that if these symptoms occur, along with headache, fatigue, or a rapid heart rate, it is officially advised that emergency medical attention be sought immediately.

Q: Can a pregnant or breastfeeding partner use this product with their partner?

Official regulatory documents advise that if the partner is pregnant or breastfeeding, users should seek advice from a healthcare professional before using this product. The active ingredient, Benzocaine, has safety restrictions related to its use, and a qualified professional can assess the risk profile.

Q: What are the contraindications for co-administration with other medicines like Dapsone?

Official labeling notes that the co-administration of Benzocaine with other medicines that are known to induce methemoglobinemia, such as Dapsone or certain nitrate derivatives, can result in an additive risk of this serious blood condition. While this interaction is documented as an additive risk, it is an important safety consideration defined in regulatory sources.

Q: Can this product be used for anal sex, or only vaginal sex?

The product is regulated as a barrier contraceptive that provides protection against pregnancy and STIs. Clinical studies related to the delay component primarily measure Intravaginal Ejaculation Latency Time (IELT). The intended use of the combination product, based on the specific studies and product labeling, is primarily defined by the context of this intravaginal use.

Q: Can I keep the condom in my wallet or car for convenience?

Official storage instructions specify that the product must be stored in a cool place, away from excessive heat, humidity, and direct sunlight, and maintained below 40 C (104 F). Exposure to temperature extremes, such as those found in a car, or physical crushing forces, such as in a wallet, has the potential to compromise the integrity of the latex and the Benzocaine lubricant.

Q: Is it okay to flush used condoms down the toilet?

According to official disposal requirements, used condoms must be disposed of in the trash and should not be flushed down the toilet. Unused or expired products should also be discarded in the trash, following local regulations for pharmaceutical or medical waste.

Q: How does the benzocaine get absorbed to cause its effect?

Official pharmacological and pharmacokinetic information confirms that for the product to achieve its localized desensitizing effect, the Benzocaine must diffuse and be absorbed across the surface of the skin on the penis. This percutaneous absorption allows the drug to reach the sensory nerve endings, where it can exert its targeted anesthetic action.

Official Storage and Disposal Requirements

Storage and disposal of Durex Performa Condoms must adhere to regulatory standards to maintain the integrity of the latex and the Benzocaine lubricant.

Storage Condition	Requirement
Temperature	Store in a cool place, below 40 C (104 F).
Protection	Must be kept dry, away from high humidity, direct sunlight, fluorescent light, ozone, and chemical solvents.
Child Safety	Store out of the sight and reach of children.
Shelf Life	Labeled expiration date must be observed; maximum shelf life is limited to five years.

Used condoms must be disposed of in the trash and should not be flushed down the toilet. Unused or expired products must be discarded in accordance with local regulations for pharmaceutical or medical waste.